Transmedics Group Overview
Transmedics Group Target Price
See Transmedics Group's analyst price targets ($100) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$90.69
Average Target Price
$101.85
12.3% upside
12.3% upside13 analysts in the last 4 months
High: $142 | Low: $65
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-05 | Robert W. Baird | $122 | 34.5% upside |  |
| 2026-08-05 | Canaccord Genuity | $95 | 4.8% upside | |
| 2026-08-05 | Stifel Nicolaus | $65 |  28.3% downside | |
| 2026-08-03 | NeedhamMike Matson | $106 | 16.9% upside | |
| 2026-07-28 | UBS | $80 | 11.8% downside | |
| 2026-07-06 | Evercore ISIDaniel Markowitz | $90 | 0.8% downside | |
| 2026-06-18 | Stifel Nicolaus | $80 | 11.8% downside | |
| 2026-05-26 | Stifel NicolausThomas Stephan | $75 | 17.3% downside | |
| 2026-05-06 | Needham | $142 | 56.6% upside | |
| 2026-05-06 | Canaccord GenuityWilliam Plovanic | $124 | 36.7% upside | |
| 2026-05-06 | Piper Sandler | $120 | 32.3% upside | |
| 2026-05-06 | Stifel NicolausThomas Stephan | $85 | 6.3% downside | |
| 2026-05-06 | Robert W. BairdDavid Rescott | $140 | 54.4% upside | |
| 2026-03-09 | Stifel Nicolaus | $130 | 43.3% upside | |
| 2025-12-17 | Canaccord Genuity | $148 | 63.2% upside | |
| 2025-12-08 | Needham | $166 | 83% upside | |
| 2025-12-02 | Morgan Stanley | $135 | 48.9% upside | |
| 2025-10-30 | Piper SandlerMatt O'Brien | $140 | 54.4% upside | |
| 2025-10-30 | Canaccord GenuityJason Mills | $147 | 62.1% upside | |
| 2025-10-23 | Needham | $148 | 63.2% upside | |
| 2025-10-13 | Jefferies | $145 | 59.9% upside | |
| 2025-10-07 | Evercore ISI | $155 | 70.9% upside | |
| 2024-12-11 | Robert W. BairdDavid Rescott | $120 | 32.3% upside | |
| 2024-12-11 | Piper SandlerMatt O'Brien | $90 | 0.8% downside | |
| 2024-10-29 | Robert W. BairdJoe Vruwink | $150 | 65.4% upside | |
| 2024-10-29 | Canaccord GenuityJason Mills | $109 | 20.2% upside | |
| 2024-10-29 | NeedhamMike Matson | $109 | 20.2% upside | |
| 2024-10-29 | OppenheimerSuraj Kalia | $125 | 37.8% upside | |
| 2024-09-23 | Robert W. BairdDavid Rescott | $200 | 120.5% upside | |
| 2024-09-04 | Piper SandlerMatt O'Brien | $180 | 98.5% upside | |
| 2024-08-21 | NeedhamMike Matson | $208 | 129.4% upside | |
| 2024-08-01 | Canaccord GenuityWilliam Plovanic | $169 | 86.3% upside | |
| 2024-08-01 | OppenheimerSuraj Kalia | $200 | 120.5% upside | |
| 2024-07-15 | Morgan StanleyPatrick Wood | $145 | 59.9% upside | |
| 2024-07-15 | Piper SandlerMatt O'Brien | $170 | 87.5% upside | |
| 2024-06-03 | StephensGeorge Sellers | $151 | 66.5% upside | |
| 2023-01-06 | Morgan Stanley | $63 | 30.5% downside | |
| 2022-08-03 | Morgan Stanley | $37 | 59.2% downside | |
| 2022-08-02 | Oppenheimer | $45 | 50.4% downside | |
| 2022-07-26 | Cowen & Co. | $45 | 50.4% downside | |
| 2022-06-29 | Morgan Stanley | $34 | 62.5% downside | |
| 2022-06-28 | Cowen & Co. | $39 | 57% downside | |
| 2022-05-04 | Morgan Stanley | $25 | 72.4% downside | |